These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 34545708)
1. Hypoxia-stimulated ATM activation regulates autophagy-associated exosome release from cancer-associated fibroblasts to promote cancer cell invasion. Xi L; Peng M; Liu S; Liu Y; Wan X; Hou Y; Qin Y; Yang L; Chen S; Zeng H; Teng Y; Cui X; Liu M J Extracell Vesicles; 2021 Sep; 10(11):e12146. PubMed ID: 34545708 [TBL] [Abstract][Full Text] [Related]
2. Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-β-catenin signaling pathways. Tang S; Hou Y; Zhang H; Tu G; Yang L; Sun Y; Lang L; Tang X; Du YE; Zhou M; Yu T; Xu L; Wen S; Liu C; Liu M Cell Cycle; 2015; 14(12):1908-24. PubMed ID: 25970706 [TBL] [Abstract][Full Text] [Related]
3. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198 [TBL] [Abstract][Full Text] [Related]
4. The role of oxidized ATM in the regulation of oxidative stress-induced energy metabolism reprogramming of CAFs. Tang S; Yang L; Tang X; Liu M Cancer Lett; 2014 Oct; 353(2):133-44. PubMed ID: 25069040 [TBL] [Abstract][Full Text] [Related]
5. TCF12 regulates exosome release from epirubicin-treated CAFs to promote ER+ breast cancer cell chemoresistance. Qiu Y; Wang X; Sun Y; Du YE; Yin G; Luo H; Wen S; Lang L; Liu M; Tang X Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166727. PubMed ID: 37137433 [TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion. Yan L; Wang P; Fang W; Liang C Cell Biochem Funct; 2020 Apr; 38(3):257-265. PubMed ID: 31749189 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment. Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136 [TBL] [Abstract][Full Text] [Related]
8. ATM-Mediated Phosphorylation of Cortactin Involved in Actin Polymerization Promotes Breast Cancer Cells Migration and Invasion. Lang L; Hou Y; Chen Y; Tu G; Tao J; Yang D; Xi L; Fu L; Sun K; Yin J; Chen R; Peng M; Liu S; Liu M Cell Physiol Biochem; 2018; 51(6):2972-2988. PubMed ID: 30562756 [TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7. Yan Z; Sheng Z; Zheng Y; Feng R; Xiao Q; Shi L; Li H; Yin C; Luo H; Hao C; Wang W; Zhang B Cell Death Dis; 2021 Dec; 12(12):1120. PubMed ID: 34853307 [TBL] [Abstract][Full Text] [Related]
10. TGF-β1-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or overexpression of FAP-α. Huang M; Fu M; Wang J; Xia C; Zhang H; Xiong Y; He J; Liu J; Liu B; Pan S; Liu F Biochem Pharmacol; 2021 Jun; 188():114527. PubMed ID: 33741330 [TBL] [Abstract][Full Text] [Related]
11. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis. Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874 [TBL] [Abstract][Full Text] [Related]
12. Melanoma-derived exosomes induce reprogramming fibroblasts into cancer-associated fibroblasts via Gm26809 delivery. Hu T; Hu J Cell Cycle; 2019 Nov; 18(22):3085-3094. PubMed ID: 31544590 [TBL] [Abstract][Full Text] [Related]
13. Autophagic secretion of HMGB1 from cancer-associated fibroblasts promotes metastatic potential of non-small cell lung cancer cells via NFκB signaling. Ren Y; Cao L; Wang L; Zheng S; Zhang Q; Guo X; Li X; Chen M; Wu X; Furlong F; Meng Z; Xu K Cell Death Dis; 2021 Sep; 12(10):858. PubMed ID: 34552063 [TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871 [TBL] [Abstract][Full Text] [Related]
15. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling. Goulet CR; Champagne A; Bernard G; Vandal D; Chabaud S; Pouliot F; Bolduc S BMC Cancer; 2019 Feb; 19(1):137. PubMed ID: 30744595 [TBL] [Abstract][Full Text] [Related]
16. ATM loss disrupts the autophagy-lysosomal pathway. Cheng A; Tse KH; Chow HM; Gan Y; Song X; Ma F; Qian YXY; She W; Herrup K Autophagy; 2021 Aug; 17(8):1998-2010. PubMed ID: 32757690 [TBL] [Abstract][Full Text] [Related]
17. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis. Li BL; Lu W; Qu JJ; Ye L; Du GQ; Wan XP J Cell Physiol; 2019 Mar; 234(3):2943-2953. PubMed ID: 30146796 [TBL] [Abstract][Full Text] [Related]
18. Exosomal circHIF1A derived from hypoxic-induced carcinoma-associated fibroblasts promotes hepatocellular carcinoma cell malignant phenotypes and immune escape. Shang H; Lu L; Fan M; Lu Y; Shi X; Lu H Int Immunopharmacol; 2024 Sep; 138():112282. PubMed ID: 38936058 [TBL] [Abstract][Full Text] [Related]
19. Snail1-dependent cancer-associated fibroblasts induce epithelial-mesenchymal transition in lung cancer cells via exosomes. You J; Li M; Cao LM; Gu QH; Deng PB; Tan Y; Hu CP QJM; 2019 Aug; 112(8):581-590. PubMed ID: 31106370 [TBL] [Abstract][Full Text] [Related]
20. Hypoxic enhancement of exosome release by breast cancer cells. King HW; Michael MZ; Gleadle JM BMC Cancer; 2012 Sep; 12():421. PubMed ID: 22998595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]